Skip to main content
. 2020 Feb 11;7:396. doi: 10.3389/fcell.2019.00396

FIGURE 7.

FIGURE 7

Hypothesized pathway of CypD associated sevoflurane-induced cognitive impairment in young mice. Sevoflurane increases levels of CypD via reducing the binding of CypD with ANT. The increased CypD then causes mitochondrial dysfunctions and impairment of neurogenesis, eventually leading to cognitive impairment in young mice.